248
Participants
Start Date
September 1, 2021
Primary Completion Date
September 21, 2022
Study Completion Date
September 21, 2022
Tempol
Tempol 800 mg capsule will be administered at 400mg (2 capsules) two times daily for fourteen (14) consecutive days.
Placebo
Placebo capsules will be administered orally (2 capsules) two times daily for fourteen (14) consecutive days.
Meridian Clinical Research, Portsmouth
Monroe Biomedical Research, Monroe
Sarkis Clinical Trials, Gainesville
Omega Research Orlando, LLC, Orlando
Doral medical Research, Doral
Sunrise Research Institute, Sunrise
Pinnacle Research Group, Anniston
Clinical Trials Center of Middle Tennessee, LLC, Franklin
Dayton Clinical Research, Dayton
Center for Respiratory and Sleep Medicine, Greenwood
Barrett Clinical, La Vista
Tandem Clinical Research GI, LLC., Marrero
Vilo Research Group, Houston
United Memorial Medical Center, Houston
R&H Clinical Research, Katy
LA Universal Research, Los Angeles
Eastside Research Associates, Redmond
Lead Sponsor
Adamis Pharmaceuticals Corporation
INDUSTRY